Skip to content

News

UKDTN nominated for Parliamentary Pathfinder – NHS Innovation Adoption Awards 2025-2026

The UK Dementia Trials Network (UKDTN) is pleased to announce its nomination for the Parliamentary Pathfinder – NHS Innovation Adoption Awards 2025-2026, which recognises organisations and partnerships successfully scaling innovation across the NHS and wider health and life sciences sector.

The awards focus on real-world adoption of innovation, highlighting initiatives that deliver measurable improvements in patient outcomes, workforce capacity, prevention, and system impact, beyond early-stage pilots.

This nomination reflects UKDTN’s ongoing work to strengthen and accelerate dementia clinical trials across the UK through collaboration with NHS sites, academic partners, industry, and the wider research community.

Shortlisted nominees have been featured in a Parliamentary State of the Nation report on healthcare innovation adoption and formally recognised at the Healthcare and Life Sciences Parliamentary Showcase. The full awards ceremony will take place in Westminster in November 2026.

This recognition highlights the importance of collaboration in turning innovation into real improvements for people affected by dementia and the health system as a whole.

Other News

ARUK-UKDTN Partnership

Applications open for ARUK Doctoral Clinical Fellowship and UKDTN Clinical Trial Placement Pilot Clinicians interested in building a career in dementia clinical research are invited to apply for the Alzheimer’s Research
Click here for full report

UKDTN strengthens global partnerships at AAIC 2026 in London

UKDTN was proud to participate in the Alzheimer’s Association International Conference (AAIC) 2026, held in London. Bringing together more than 10,000 researchers, clinicians, industry leaders and healthcare professionals from across the
Click here for full report
×

Privacy Notice: This site uses no tracking or marketing cookies by default. Non-essential cookies are only used if you choose to play embedded videos. We prioritise a simple and secure experience. Cookie Policy.